These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6994265)

  • 1. Single-step selection of mouse FM3A cell mutants defective in thymidylate synthetase.
    Ayusawa D; Koyama H; Iwata K; Seno T
    Somatic Cell Genet; 1980 Mar; 6(2):261-70. PubMed ID: 6994265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of mammalian thymidine auxotrophic cell mutants defective in thymidylate synthase by their reduced sensitivity to methotrexate.
    Ayusawa D; Koyama H; Iwata K; Seno T
    Somatic Cell Genet; 1981 Sep; 7(5):523-34. PubMed ID: 7292255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidylate synthetase-deficient mouse FM3A mammary carcinoma cell line as a tool for studying the thymidine salvage pathway and the incorporation of thymidine analogues into host cell DNA.
    Balzarini J; De Clercq E; Ayusawa D; Seno T
    Biochem J; 1984 Jan; 217(1):245-52. PubMed ID: 6696722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assignment of human gene encoding thymidylate synthase to chromosome 18 using interspecific cell hybrids between thymidylate synthase-negative mouse mutant cells and human diploid fibroblasts.
    Hori T; Ayusawa D; Shimizu K; Koyama H; Seno T
    Somat Cell Mol Genet; 1985 May; 11(3):277-83. PubMed ID: 3859022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to methotrexate in thymidylate synthetase-deficient mutants of cultured mouse mammary tumor FM3A cells.
    Ayusawa D; Koyama H; Seno T
    Cancer Res; 1981 Apr; 41(4):1497-501. PubMed ID: 6452198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional thymidine auxotrophic mutants of mouse FM3A cells due to thermosensitive thymidylate synthase and their prototrophic revertants.
    Ayusawa D; Iwata K; Seno T; Koyama H
    J Biol Chem; 1981 Dec; 256(23):12005-12. PubMed ID: 7298639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of 5-substituted pyrimidine nucleoside analogues into DNA of a thymidylate synthetase-deficient murine FM3A carcinoma cell line.
    Balzarini J; De Clercq E; Ayusawa D; Seno T
    Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):19-28. PubMed ID: 3990443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidylate synthetase-positive and -negative murine mammary FM3A carcinoma cells as a useful system for detecting thymidylate synthetase inhibitors.
    Balzarini J; de Clercq E; Ayusawa D; Seno T
    FEBS Lett; 1984 Jul; 173(1):227-32. PubMed ID: 6745430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutants of Chinese hamster cells deficient in thymidylate synthetase.
    Li IC; Chu EH
    J Cell Physiol; 1984 Aug; 120(2):109-16. PubMed ID: 6611339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidine 5'-monophosphate-requiring mutants of Saccharomyces cerevisiae are deficient in thymidylate synthetase.
    Bisson L; Thorner J
    J Bacteriol; 1977 Oct; 132(1):44-50. PubMed ID: 334734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of mouse FM3A cell mutants with thermolabile thymidylate synthetase by resistance to aphidicolin.
    Ayusawa D; Iwata K; Seno T
    Biochem Biophys Res Commun; 1980 Oct; 96(4):1654-61. PubMed ID: 6778479
    [No Abstract]   [Full Text] [Related]  

  • 12. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual sensitivity to bleomycin and joint resistance to 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine of mouse FM3A cell mutants with altered ribonucleotide reductase and thymidylate synthase.
    Ayusawa D; Iwata K; Seno T
    Cancer Res; 1983 Feb; 43(2):814-8. PubMed ID: 6184158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual aspects of human thymidylate synthase in mouse cells introduced by DNA-mediated gene transfer.
    Ayusawa D; Shimizu K; Koyama H; Takeishi K; Seno T
    J Biol Chem; 1983 Jan; 258(1):48-53. PubMed ID: 6848516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of functional cDNA clones for human thymidylate synthase.
    Ayusawa D; Takeishi K; Kaneda S; Shimizu K; Koyama H; Seno T
    J Biol Chem; 1984 Dec; 259(23):14361-4. PubMed ID: 6094554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidineless death and mutation induction in cultured mouse FM3A cell mutants deficient in thymidylate synthase.
    Koyama H; Ayusawa D; Tsuji M; Seno T
    Mutat Res; 1982 Dec; 105(6):433-8. PubMed ID: 7155163
    [No Abstract]   [Full Text] [Related]  

  • 17. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Seno T
    Mol Pharmacol; 1985 Dec; 28(6):581-7. PubMed ID: 3001499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome breakage induced by thymidylate stress in thymidylate synthase-negative mutants of mouse FM3A cells.
    Hori T; Ayusawa D; Shimizu K; Koyama H; Seno T
    Cancer Res; 1984 Feb; 44(2):703-9. PubMed ID: 6692373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of thymidylate synthetase in mouse leukemia cells (L1210).
    Rode W; Scanlon KJ; Moroson BA; Bertino JR
    J Biol Chem; 1980 Feb; 255(4):1305-11. PubMed ID: 6965493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of mutant FM3A murine mammary carcinoma cell strains transformed with the herpes simplex virus type 1 thymidine kinase gene.
    Ayusawa D; Shimizu K; Seno T; Balzarini J; De Clercq E
    Jpn J Cancer Res; 1985 Oct; 76(10):984-8. PubMed ID: 3001011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.